Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2003
12/31/2003WO2004000328A1 Biosynthesis of hif
12/31/2003WO2004000313A2 Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds
12/31/2003WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor
12/31/2003WO2004000284A1 Pharmaceutical compositions with improved dissolution
12/31/2003WO2004000228A2 Methods for preventing and treating microbial infections by modulating transcription factors
12/31/2003WO2004000102A2 Method for predicting response to epidermal growth factor receptor-directed therapy
12/31/2003WO2004000096A2 Novel bartonella antigen lysate extracts for use in elisa diagnostic
12/31/2003WO2004000094A2 Predictive markers in cancer therapy
12/31/2003WO2004000009A2 Methods for selection for efficient animal growth
12/31/2003WO2004000003A2 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process
12/31/2003WO2003087830A3 Timp-1 as a postoperative marker for recurrent cancer
12/31/2003WO2003087817A3 Device and method for measuring coagulation time and platelet activity
12/31/2003WO2003087774A3 Ecist microarrays for dual screening of dna hypermethylation and gene silencing
12/31/2003WO2003083487A3 Method of screening of compounds inducing a prolonged qt intervalon the electrocardiogram
12/31/2003WO2003081244A3 Method of electrochemical cell analysis
12/31/2003WO2003080869A3 Storing and detecting nucleic acid administered to a solid carrier
12/31/2003WO2003078974A3 Improved method for on-line monitoring of lubricating oil using light in the visible and near ir spectra
12/31/2003WO2003078582A3 Integrated system for high throughput capture of genetic diversity
12/31/2003WO2003076658A3 A susceptibility gene for late-onset idiopathic parkinson's disease
12/31/2003WO2003076476A3 Magnetically detectable latex articles
12/31/2003WO2003075839A3 Methods of inducing terminal differentiation
12/31/2003WO2003075129A3 Methods, systems, and software for identifying functional bio-molecules
12/31/2003WO2003070876A3 Method for attaching nucleic acid molecules to electrically conductive surfaces
12/31/2003WO2003069421A3 Methods and algorithms for cell enumeration in a low-cost cytometer
12/31/2003WO2003069309A3 Immunocapture and functional assay for mitochondrial complex i
12/31/2003WO2003068981A3 Method for reducing background contamination after marking reactions
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003065795A3 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
12/31/2003WO2003064995A3 A guided mode resonant filter biosensor using a linear grating surface structure
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003062789A3 Methods for isolating and characterizing short-lived proteins and arrays derived therefrom
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003061453A3 Device and method for the identification of analytes in bodily fluids
12/31/2003WO2003057719A3 Methods of modulating localization and physiological function of ip3 receptors
12/31/2003WO2003056034A3 Method for the in vitro selection of binders
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003052138A3 Methods of detecting modification of genetic material
12/31/2003WO2003048191A3 Process for the selective alkylation of -sh groups in proteins and peptides for the study of complex protein mixtures
12/31/2003WO2003047606A3 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
12/31/2003WO2003046507A3 Apparatus used in identification, sorting and collection methods using magnetic microspheres and magnetic microsphere kits
12/31/2003WO2003046129A3 Compositions for the derivation of germ cells from stem cells and methods of use thereof
12/31/2003WO2003040685A3 Diagnosis demyelinating or spongiform disease
12/31/2003WO2003039349A3 Method of using physiological markers to estimate cardiovascular risk
12/31/2003WO2003038440A3 Chemokine binding molecules
12/31/2003WO2003038399A3 Chemiluminescent acridinium compounds and their use in an assay to detect analytes
12/31/2003WO2003033667A3 Use of mx gtpases in the prognosis and treatment of cancer
12/31/2003WO2003029814A3 Neuropilin/vegf c/vegfr 3 materials and methods
12/31/2003WO2003027122A3 Lanthanide binding tags
12/31/2003WO2003023353A3 Particle based homogeneous assays using capillary electrophoresis with laser-induced fluorescence detection
12/31/2003WO2003023035A3 Glucosyltransferases which glucosylate abscisic acid
12/31/2003WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003016566A3 Improvements relating to capillary gel array analysis
12/31/2003WO2003001985A3 Method for detection of melanoma
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002087769A3 Method for parallel synthesis and transfer of molecules to a substrate
12/31/2003WO2002079767A8 Method and apparatus for determination of gastrointestinal intolerance
12/31/2003WO2002077648A3 Pathogenic and commensal vaccine antigens
12/31/2003WO2002071070A3 β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002066984A3 Arrays for determining binding of biomolecules
12/31/2003WO2002066955A8 Method for screening compounds
12/31/2003WO2002057989A3 Method for metabolic profiling
12/31/2003WO2002054081A3 Proteins, genes and their use for diagnosis and treatment of kidney response
12/31/2003WO2002044714A8 System and method for integrated analysis of data for characterizing carbohydrate polymers
12/31/2003WO2002043578A3 Determination of risk and treatment of complications of prematurity
12/31/2003WO2002042779A3 Axonal response to chemotropic gradients
12/31/2003WO2002042775A3 Clinically intelligent diagnostic devices and methods
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040962A3 Methods and reagents to reduce backgrounds of heterogeneous assays
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002038143A3 Enhanced efficacy and safety of genotoxic therapy by p38 mapk modulation
12/31/2003WO2002036820A8 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
12/31/2003WO2002031198A3 Cancer-linked genes as targets for chemotherapy
12/31/2003WO2002023199A8 Method, system, apparatus and device for discovering and preparing chemical compounds
12/31/2003WO2002018635A8 Use of nonviable particles comprising an internal control (ic) nucleic acid
12/31/2003WO2001088197A3 Methods and compositions for interaction trap assays
12/31/2003WO2001082216A8 Multi-neural net imaging apparatus and method
12/31/2003CN2596361Y Peptide nucleic acid detection chip for hepatitis B virus mutational site
12/31/2003CN2596360Y Flowing biological chip
12/31/2003CN2596359Y Integrated device for preparing biological molecular chip and instant detection
12/31/2003CN2596354Y Soft package molk quality detector
12/31/2003CN2596348Y Laser fresh molk fat protein content detector
12/31/2003CN1464977A Biosensor and method for analyzing blood components using it
12/31/2003CN1464909A Cell diagnosing method, and device and apparatus used for it
12/31/2003CN1464309A Usage of alpha-mannosidase in the immunocyte subgroup sectionalization and method thereof
12/31/2003CN1464308A A polypeptide chip agent box and uses thereof
12/31/2003CN1464307A Embedded high-pass three-dimensional biological detecting technique and agent box
12/31/2003CN1464306A Human leulocyte antigens genotyping chip, method for preparing the same and method for detecting human leukocyte antigens
12/31/2003CN1464305A Novel process for determining herb character
12/31/2003CN1464304A Probe board containing enclosed type reactor and use thereof
12/31/2003CN1464303A Process for preparing high polymer micro-flow control chips
12/31/2003CN1464300A Apparatus for continuous and automatic measurement of radial flow sediment content
12/31/2003CN1464066A Alpha-fucosidase monostable liquid detecting reagent
12/31/2003CN1464064A Process for preparing telomeric repeat binding factor (TRF1) monoclonal antibodies and use thereof
12/31/2003CN1464059A Actinine fluorescent protein novel gene and its cloning, expression and use
12/31/2003CN1464001A Chloro-silicane polyethylene derivative, process for synthesizing and use thereof
12/31/2003CN1464000A Chloro-silicane polyethylene derivative, process for synthesizing and use thereof
12/31/2003CN1463985A Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom
12/31/2003CN1133077C Method for diagnosing autoimmune diseases